| PERIOD ENDING | 2-Aug-09 | 3-May-09 | 1-Feb-09 | 2-Nov-08 | | Total Revenue | 11,444 | 12,588 | 12,706 | 13,031 | | Cost of Revenue | 4,934 | 4,668 | 5,468 | 5,781 | | | Gross Profit | 6,510 | 7,920 | 7,238 | 7,250 | | | Operating Expenses | | Research Development | 1,373 | 1,312 | 1,391 | 1,330 | | Selling General and Administrative | 4,636 | 6,310 | 5,463 | 5,843 | | Non Recurring |
-
|
-
|
-
| 10,780 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 501 | 298 | 384 | (10,703) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (146) | 75 | 54 | (2,326) | | Earnings Before Interest And Taxes | 355 | 373 | 438 | (13,029) | | Interest Expense | 316 | 519 | 1,520 | 2,474 | | Income Before Tax | 39 | (146) | (1,082) | (15,503) | | Income Tax Expense | 129 | (77) | (399) | (4,384) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (90) | (69) | (683) | (11,119) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (90) | (69) | (683) | (11,119) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($90) | ($69) | ($683) | ($11,119) |
|
0.51% Nasdaq 
0.03 (2.48%) 
Income Statement
